Document is current
Any future updates will be listed below
-
Authors
Ritterband, Lee M.
Shaffer, Kelly M.
Thorndike, Frances P.
Chow, Philip I.
Gonder-Frederick, Linda
Ingersoll, Karen S.
Cohn, Wendy F.
Frederick, Christina
MacDonnell, Kirsten
Glazer, Jillian V.
Mattos, Meghan K.
Hilgart, Michelle M.
Quigg, Mark S.
Bashir, Mudhasir
Morin, Charles M.
-
Funding
Funding for this research was provided by:
National Institute of Aging (R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885, R01AG047885)
- License Information
-
More Information
Article History
Received: 6 February 2025
Accepted: 28 June 2025
First Online: 19 July 2025
Competing interests
: K.M.S., P.I.C., K.S.I., W.F.C., C.F., K.M., J.V.G., M.K.M., M.M.H., M.S.Q. and M.B. have no financial conflicts of interest to report. L.M.R., F.P.T., L.G.-F. and C.M.M. report having equity ownership in BeHealth Solutions, L.L.C., the company that was originally established to make available digital health products, including Sleep Healthy Using the Internet, now licensed by Nox Health. F.P.T. is an employee of Nox Health, which owns the IP of Somryst, a commercial PDT for insomnia based on the SHUTi program. L.M.R. and C.M.M. are paid consultants of Nox Health. C.M.M. has also served on advisory boards for Eisai, Merck, and Phillips; served as consultant for Eisai, Merck, Sunovion, and Weight Watchers; received research support from Eisai, Idorsia, Canopy Health, and Lallemand Health. These companies had no role in the preparation of this manuscript. The terms of these arrangements have been reviewed and approved by the University of Virginia in accordance with its policies.
